Published in Recenti Prog Med on May 01, 2011
Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension (2006) 4.20
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol (2006) 3.74
Oxidative stress in patients affected by primary aldosteronism. J Hypertens (2014) 3.34
Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension (2012) 2.31
Epidemiology of acute myocardial infarction in the Italian CCU network: the BLITZ study. Eur Heart J (2003) 1.76
Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab (2009) 1.53
The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma. J Hypertens (2010) 1.46
Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism. Hypertension (2009) 1.45
Dipyridamole versus verapamil for treatment of no-reflow during primary angioplasty. Catheter Cardiovasc Interv (2010) 1.43
The functional HERG variant 897T is associated with Conn's adenoma. J Hypertens (2006) 1.41
Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J Clin Endocrinol Metab (2008) 1.38
Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects. Arch Dermatol Res (2010) 1.30
A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs >or=5 days in community-acquired intraabdominal infection. J Gastrointest Surg (2007) 1.19
Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension (2007) 1.13
The impact of epithelial-mesenchymal transition on R1 status of the mesopancreatic resection margin after pancreaticoduodenectomy for pancreatic carcinoma: a research proposal topic. Eur J Cancer (2013) 1.11
Gastrointestinal and retroperitoneal manifestations of type 1 neurofibromatosis. J Gastrointest Surg (2010) 1.05
Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study). Am J Cardiol (2009) 1.05
Feasibility of inter-hospital transportation using extra-corporeal membrane oxygenation (ECMO) support of patients affected by severe swine-flu(H1N1)-related ARDS. Scand J Trauma Resusc Emerg Med (2011) 1.05
Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects. Osteoporos Int (2004) 1.03
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. J Clin Endocrinol Metab (2007) 1.02
TRIM proteins in cancer. Adv Exp Med Biol (2012) 1.00
Epidemiology of non-ST elevation acute coronary syndromes in the Italian cardiology network: the BLITZ-2 study. Eur Heart J (2005) 0.99
Enucleation for gastrointestinal stromal tumors at the esophagogastric junction: is this an adequate solution? World J Gastroenterol (2011) 0.99
Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J Hypertens (2007) 0.96
Adrenocortical carcinoma extending into the inferior vena cava in a patient with right kidney agenesis: Surgical approach and review of literature. Int J Surg Case Rep (2012) 0.95
Adipokines and cardiometabolic profile in primary hyperaldosteronism. J Clin Endocrinol Metab (2010) 0.95
Surgical management of abdominal manifestations of type 1 neurofibromatosis: experience of a single center. Am Surg (2010) 0.93
Multiple catecholamine-secreting paragangliomas: diagnosis after hemorrhagic stroke in a young woman. Endocr Pract (2008) 0.92
Pancreaticojejunostomy with application of fibrinogen/thrombin-coated collagen patch (TachoSil) in Roux-en-Y reconstruction after pancreaticoduodenectomy. J Gastrointest Surg (2009) 0.91
Body composition changes and cardiometabolic benefits of a balanced Italian Mediterranean Diet in obese patients with metabolic syndrome. Acta Diabetol (2012) 0.91
Erectile dysfunction in systemic sclerosis: effects of longterm inhibition of phosphodiesterase type-5 on erectile function and plasma endothelin-1 levels. J Rheumatol (2007) 0.88
Ovarian malignancies with cytologically negative pleural and peritoneal effusions: demons' or meigs' pseudo-syndromes? Int J Surg Pathol (2009) 0.87
Clinical characteristics and outcome of diabetic patients with acute myocardial infarction. Data from the BLITZ-1 study. Ital Heart J (2005) 0.87
Thyroid cancer in patients with hyperthyroidism. Horm Res (2003) 0.87
99mTc-EDDA/HYNIC-TOC in the management of medullary thyroid carcinoma. Cancer Biother Radiopharm (2004) 0.86
von Hippel Lindau disease with colon adenocarcinoma, renal cell carcinoma and adrenal pheochromocytoma. Intern Med (2013) 0.85
Increased HMGB1 expression and release by mononuclear cells following surgical/anesthesia trauma. Crit Care (2010) 0.85
Epicardial fat thickness and left ventricular mass in subjects with adrenal incidentaloma. Endocrine (2013) 0.85
Clinical epidemiology, management and outcome of acute coronary syndromes in the Italian network on acute coronary syndromes (IN-ACS Outcome study). Acute Card Care (2012) 0.84
Regulation by hypoxia of adrenomedullin output and expression in human trophoblast cells. Eur J Obstet Gynecol Reprod Biol (2010) 0.84
Small intestine contrast ultrasonography (SICUS) for the detection of small bowel complications in crohn's disease: a prospective comparative study versus intraoperative findings. Inflamm Bowel Dis (2011) 0.84
KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism. J Hypertens (2014) 0.83
Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects. Obesity (Silver Spring) (2013) 0.83
High plasma levels of human chromogranin A and adrenomedullin in patients with pheochromocytoma. Tumori (2005) 0.83
Adrenomedullin in perinatal medicine. Regul Pept (2003) 0.82
Prescription at discharge of recommended treatments for secondary prevention in patients with ST-segment elevation myocardial infarction according to reperfusion strategies. Results from the IN-ACS outcome study. Acute Card Care (2009) 0.82
Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score. EuroIntervention (2012) 0.81
Leptin and adiponectin mRNA expression from the adipose tissue surrounding the adrenal neoplasia. J Clin Endocrinol Metab (2015) 0.81
Early and long-term outlook of percutaneous coronary intervention for bifurcation lesions in young patients. Int J Cardiol (2012) 0.81
Sudden death and physical exercise: timely diagnosis of congenital anomalies of the coronary arteries with the new 320-slide multi-detector computed tomography. Intern Emerg Med (2013) 0.81
Splenic infarction, rare cause of acute abdomen, only seldom requires splenectomy. Case report and literature review. Ann Ital Chir (2008) 0.81
Tumor rupture during surgery for gastrointestinal stromal tumors: pay attention! World J Gastroenterol (2013) 0.81
Effects of unilateral ovariectomy on female fertility outcome. Arch Gynecol Obstet (2014) 0.81
Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling. J Clin Endocrinol Metab (2012) 0.81
Increased risk of cardiac death in primary hyperparathyroidism: what is a role of electrical instability? Int J Cardiol (2006) 0.81
A spontaneous, double-blind, double-dummy cross-over study on the effects of daily vardenafil on arterial stiffness in patients with vasculogenic erectile dysfunction. Int J Cardiol (2011) 0.81
Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry. Clin Res Cardiol (2011) 0.80
Imaging coronary and extracoronary atherosclerosis: feasibility and impact of whole-body computed tomography angiography. Eur Radiol (2009) 0.80
Clinical experience with pheochromocytoma in a single centre over 16 years. High Blood Press Cardiovasc Prev (2013) 0.80
Comparison of atorvastatin versus fenofibrate in reaching lipid targets and influencing biomarkers of endothelial damage in patients with familial combined hyperlipidemia. Metabolism (2007) 0.80
Intracoronary adiponectin levels rapidly and significantly increase after coronary revascularization. Int J Cardiol (2009) 0.80
Pancreato-jejunostomy versus hand-sewn closure of the pancreatic stump to prevent pancreatic fistula after distal pancreatectomy: a retrospective analysis. BMC Surg (2013) 0.80
Pigmented 'black' cardiac paraganglioma in a patient with a novel germ-line SDHD mutation. Eur J Cardiothorac Surg (2008) 0.80
An unusual case of ST-segment elevation myocardial infarction following a late bare-metal stent fracture in a native coronary artery: a case report. J Med Case Rep (2009) 0.80
Use of levosimendan for cardiogenic shock in a patient with the apical ballooning syndrome. Ann Intern Med (2008) 0.80
Role of growth factors on human parathyroid adenoma cell proliferation. World J Surg (2010) 0.80
Primary aldosteronism in a patient who exhibited heart failure. J Clin Hypertens (Greenwich) (2012) 0.79
Clinical effects of laparotomy with perioperative continuous peritoneal lavage and postoperative hemofiltration in patients with severe acute pancreatitis. World J Emerg Surg (2009) 0.79
Venous endotelin-1 (ET-1) and brain natriuretic peptide (BNP) plasma levels during 6-month bosentan treatment for pulmonary arterial hypertension. Regul Pept (2008) 0.79
Gabexate mesilate (FOY) inhibition of amylase and phospholipase A(2) activity in sow pancreatic juice. J Invest Surg (2004) 0.79
Lymph node ratio, number of excised nodes and sentinel-node concepts in breast cancer. Breast Cancer Res Treat (2010) 0.79
Effects of gabexate mesilate (FOY) on amylase and phospholipase A2 in human serum and pancreatic juice. Dig Dis Sci (2005) 0.79